[SYRS] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
05-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -13.32%
YoY- 1.55%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 5,162 4,827 5,699 3,828 3,188 2,379 508 369.80%
PBT -22,490 -14,228 -30,130 -19,486 -17,196 -17,226 -19,729 9.13%
Tax 969 967 1,417 0 0 0 0 -
NP -22,490 -14,228 -30,130 -19,486 -17,196 -17,226 -19,729 9.13%
Tax Rate - - - - - - - -
Total Cost 27,652 19,055 35,829 23,314 20,384 19,605 20,237 23.15%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -435.68 -294.76 -528.69 -509.04 -539.40 -724.09 -3,883.66 -76.77%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -3.60 -2.32 -4.91 -4.26 -3.76 -3.92 -4.60 -15.08%
EPS Diluted -3.58 -2.32 -4.91 -4.26 -3.76 -3.92 -4.49 -14.02%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.